Log in

Your Resource for Neurotherapeutics Discovery and Development

  • Home
  • Annual Meeting

Annual Meeting Overview


Join us from the comfort of your home, office or lab for the 2023 American Society for Experimental Neurotherapeutics Annual Meeting (ASENT 2023) from March 13-15, 2023. 

ASENT's 2023 Annual Meeting is the premier neuroscience and neurotherapeutics conference where senior leaders from healthcare payers, providers and prescribers, employers, investors, fast-growing startups, big pharma, policymakers, funders and innovation centers gather to improve the process of bringing neurotherapeutics to market.

The Meeting features nine symposia, which address therapeutic advances in a broad range neurologic disease states, processes and delivery methods; as well as interactive poster presentations, ASENT's celebrated pipeline presentations, and live discussion with speakers at the end of each day. 

Meeting Highlights 

  • ASENT-AAN Symposia: Drug Discovery: The Last Mile in Bringing Drugs to Market
  • The Brain-Gut connection in Neurodegenerative diseases
  • Novel Approaches to Therapy in Epilepsy
  • ASENT-JSNT Symposia: Neuro-enabled: Next Generation Prosthetics to Restore Function
  • The Role of Neuroinflammation in Acute Injury to the Nervous System
  • Bioelectronic Devices as Therapeutics
  • Opportunities and Obstacles for Innovators Entering the Field of Neurotherapeutics
  • Emerging targets and novel approaches in Parkinson’s Disease
  • Discovery and Development of Psychedelics for Neuropsychiatric Disorders
  • Interactive Poster Discussions
  • Dynamic Pipeline Presentations
  • Live Discussions in Breakout Rooms with Speakers
  • And much, much more!

Meeting Location
Virtual/Online Only

Who Attends

Physician-Scientists | Neurologists | Neuroscientists | Drug and Device Companies | Fellows | Post-docs | Founders | Funders | Industry Leaders | Nonprofit Organizations and Advocacy Groups | Journal Editors | Representatives from NIH, NIA, NIDA, NINDS and FDA

Neurology students and residents interested in neurotherapeutic development will benefit from the insight of senior investigators and leaders in industry, while private practice neurologists considering entering the clinical trial space will benefit from lessons learned by ASENT leadership. The Annual Meeting features career development sessions that offer strategies for achieving professional success in the field of neurotherapeutics. 

Upcoming events

    • November 13, 2022
    • January 27, 2023
    • 11:59 PM
    • Virtual

    Submitting an Abstract to ASENT

    The Abstract Review Committee is committed to presenting the best in neurotherapeutic research at the ASENT Annual Meeting.

    Upon registering and paying the abstract fee, you will be sent a confirmation email with a link to the Abstract Submission System. If you have not used our partner, Oxford Abstracts, you will be asked to create an account. This will allow you to edit your submission as needed.

    Below you will find details regarding Posters, Pipeline, Eligibility and the Benefits of submitting.

    All abstracts are evaluated by experts in Neurotherapeutics according to the following criteria and overall merit: 

    1. Scientific or clinical impact
    2. Quality of data, analysis, and presentation
    3. Relevance to the discovery and/or development of neurotherapeutics and inclusion of novel targets or new initiatives.
    4. Abstracts must be submitted, presented, and cited in English.

    The abstract should describe original research broadly relevant to the goal of ASENT, which is to encourage and advance the development of improved therapies for diseases and disorders of the nervous system. Please check your abstract carefully for typographical errors, misspellings, etc. Be sure to include data results.


    Title: Sentence Case (Max 50 Words)
    Abstract Body: One Paragraph with no subheadings and no tables or graphs (Max 250 Words) Include a sentence on study's purpose, brief description of methods, summary of results, and statement of conclusions reached.
    Authors: Sentence Case

    FAQs on Eligibility

    Abstracts that have been previously presented at other recent scientific meetings, or submitted for consideration to other scientific meetings, ARE ELIGIBLE.

    International and traditionally underrepresented submissions ARE ENGOURAGED.

    Private, Public and Startup Companies ARE ELIGIBLE to submit. 

    NOTE: Case studies are not considered whereas, Trials in Progress are accepted if they can show a novel trial design or new development.

    Poster Presentations

    If your abstract is selected for a poster, you will need to be available to participate in one of the two live poster discussions at the annual meeting.

    Pipeline Presentations

    Submitted abstracts that most closely conform to the above criteria and the ASENT goals may also be selected for a 10-minute oral presentation at one of our Pipeline Presentation sessions.   ASENT encourages abstracts from private, public and startup companies and government or academic labs that contain neurotherapeutic research results.

    The ASENT Annual Meeting attracts leaders in neurotherapeutics from all over the world, in all disease states. Pipeline presentations increase exposure to strategic partners in life sciences who have supported novel approaches through partnerships or strategic investments.  

    Past presenters have reported the following results:

    • sharp increases in stock values in the days following the presentation
    • financially beneficial partnerships as a result of presentation
    • developed new companies as a result of participation in meeting

    For questions regarding abstracts, please email

    • March 13, 2023
    • 10:00 AM
    • March 15, 2023
    • 5:00 PM
    • Virtual

    ABOUT ASENT 2023 Annual Meeting

    ASENT 2023 is the premier neuroscience and neurotherapeutics conference where senior leaders from leading payers, providers, employers, investors, fast-growing startups, pharma, policymakers, funders and innovation centers gather with one central focus, improving the process of bringing neurotherapeutics to market.

    The plenary sessions, panel discussions, outstanding pipeline presentations and poster sessions focus on the latest science in neurotherapeutics Topics include innovations in clinical trial design, the brain-gut connection in neurodegenerative disease states, novel approaches to drug discovery, the use of AI in neurotherapeutics, the interplay between neuroinflammation and acute injury, bioelectronic devices as therapeutics, the expanding use of psychadelics in neuropsychiatric disorders, opportunities for those entering the field, and of course the latest drug therapies and devices.


    Physician-Scientists | Neurologists | Neuroscientists | Drug and Device Companies | Fellows | Post-docs | Founders | Funders | Industry Leaders | Nonprofit Organizations and Advocacy Groups | Journal Editors | Representatives from NIH, NIA, NIDA, NINDS and FDA

Powered by Wild Apricot Membership Software